References
Key articles
Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.Full text Abstract
Reference articles
1. Camilleri M, Parkman HP, Shafi MA, et al; American College of Gastroenterology. Management of gastroparesis. Am J Gastroenterol. 2013;108:18-37;quiz 38.Full text Abstract
2. Dong K, Yu XJ, Li B, et al. Advances in mechanisms of postsurgical gastroparesis syndrome and its diagnosis and treatment. Chin J Dig Dis. 2006;7(2):76-82. Abstract
3. Balaji NS, Crookes PF, Banki F, et al. A safe and noninvasive test for vagal integrity revisited. Arch Surg. 2002 Aug;137(8):954-8. Abstract
4. Jacob A, Pittock SJ. Gastroparesis in multiple sclerosis. Mult Scler. 2007 Jun;13(5):686. Abstract
5. Raghav S, Kipp D, Watson J, et al. Gastroparesis with multiple sclerosis. Mult Scler. 2006 Apr;12(2):243-4. Abstract
6. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10;161(16):1989-96. Abstract
7. Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000 Oct 9;160(18):2808-16. Abstract
8. Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001 Jul;24(7):1264-9. Abstract
9. Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med. 1987 Jul;28(7):1204-7. Abstract
10. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut. 1996 Aug;39(2):299-305. Abstract
11. Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.Full text Abstract
12. Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology. 1985 May;88(5 Pt 1):1223-31. Abstract
13. Balaban DH, Chen J, Lin Z, et al. Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am J Gastroenterol. 1997 Mar;92(3):519-23. Abstract
14. Patrick A, Epstein O. Review article: gastroparesis. Aliment Pharmacol Ther. 2008 May;27(9):724-40.Full text Abstract
15. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999 Jun;44(6):1061-75. Abstract
16. Hinder RA, Kelly KA. Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg. 1977 Jan;133(1):29-33. Abstract
17. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998 Nov;43(11):2398-2404. Abstract
18. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986 Jul;91(1):94-9. Abstract
19. Houghton LA, Read NW, Heddle R, et al. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology. 1988 Jun;94(6):1285-91. Abstract
20. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986 Jun;90(6):1919-25. Abstract
21. Forster J, Damjanov I, Lin Z, et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg. 2005 Jan;9(1):102-8. Abstract
22. Zarate N, Mearin F, Wang XY, et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut. 2003 Jul;52(7):966-70. Abstract
23. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology. 1995 Mar;108(3):727-36. Abstract
24. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990 Nov;33(11):675-80. Abstract
25. Hunter RJ, Metz DC, Morris JB, et al. Gastroparesis: a potential pitfall of laparoscopic Nissen fundoplication. Am J Gastroenterol. 1996 Dec;91(12):2617-8. Abstract
26. Reddymasu SC, Bonino J, McCallum RW. Gastroparesis secondary to a demyelinating disease: a case series. BMC Gastroenterol. 2007 Jan 31;7:3. Abstract
27. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998 Nov;43(11):2398-404. Abstract
28. Cetin K, Gungor B, Isik A, et al. The effect of pneumatic balloon dilatation on gastric emptying in patients with achalasia. Hepatogastroenterology. 2003 Dec;50(suppl 2):ccci-cccii. Abstract
29. Benini L, Sembenini C, Salandini L, et al. Gastric emptying of realistic meals with and without gluten in patients with coeliac disease. Effect of jejunal mucosal recovery. Scand J Gastroenterol. 2001 Oct;36(10):1044-8. Abstract
30. Perri F, Pastore M, Zicolella A, et al. Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr. 2000 Aug;89(8):921-5. Abstract
31. Zipfel S, Sammet I, Rapps N, et al. Gastrointestinal disturbances in eating disorders: clinical and neurobiological aspects. Auton Neurosci. 2006 Oct 30;129(1-2):99-106. Abstract
32. Goetze O, Wieczorek J, Mueller T, et al. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett. 2005 Mar 3;375(3):170-3. Abstract
33. Goetze O, Nikodem AB, Wiezcorek J, et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil. 2006 May;18(5):369-75. Abstract
34. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol. 1996 Nov;8(6):569-75. Abstract
35. Sridhar KR, Lange RC, Magyar L, et al. Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications. J Lab Clin Med. 1998 Dec;132(6):541-6. Abstract
36. Marie I, Levesque H, Ducrotte P, et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol. 2001 Jan;96(1):77-83. Abstract
37. Shih WJ, DeLand FH, Domstad PA, et al. Scintigraphic findings in primary amyloidosis of the heart and stomach. Clin Nucl Med. 1985 Jul;10(7):466-7. Abstract
38. Jonderko G, Jonderko K, Marcisz C, et al. Evaluation of gastric emptying in patients with hypothyroidism [in Polish]. Pol Arch Med Wewn. 1996 Aug;96(2):117-23. Abstract
39. Kahraman H, Kaya N, Demircali A, et al. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol. 1997 Sep;9(9):901-4. Abstract
40. Van Vlem B, Schoonjans R, Vanholder R, et al. Dyspepsia and gastric emptying in chronic renal failure patients. Clin Nephrol. 2001 Oct;56(4):302-7. Abstract
41. Van Vlem B, Schoonjans R, Vanholder R, et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis. 2000 Nov;36(5):962-8. Abstract
42. Naftali T, Yishai R, Zangen T, et al. Post-infectious gastroparesis: clinical and electrogastrographic aspects. J Gastroenterol Hepatol. 2007 Sep;22(9):1423-8. Abstract
43. Eisenberg D. Gastroparesis and herpes. Dig Dis Sci. 1988 Aug;33(8):1050. Abstract
44. Caras S, Laurie S, Cronk W, et al. Case report: pancreatic cancer presenting with paraneoplastic gastroparesis. Am J Med Sci. 1996 Jul;312(1):34-6. Abstract
45. Berghmans T, Musch W, Brenez D, et al. Paraneoplastic gastroparesis [in French]. Rev Med Brux. 1993 Nov-Dec;14(9-10):275-8. Abstract
46. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004 Oct;16(suppl 2):17-28. Abstract
47. Parkman HP, Trate DM, Knight LC, et al. Cholinergic effects on human gastric motility. Gut. 1999 Sep;45(3):346-54. Abstract
48. Foxx-Orenstein A, Camilleri M, Stephens D, et al. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut. 2003 Nov;52(11):1555-61. Abstract
49. Tougas G, Earnest DL, Chen Y, et al. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Aliment Pharmacol Ther. 2005 Jul 1;22(1):59-65. Abstract
50. Nishiguchi S, Shiomi S, Kurooka H, et al. Randomized trial assessing gastric emptying in patients with chronic hepatitis C during interferon-alpha or -beta therapy and effect of cisapride. Dig Dis Sci. 2002 Jan;47(1):73-8. Abstract
51. Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord. 2001 Nov;16(6):1041-7. Abstract
52. Young A. Inhibition of gastric emptying. Adv Pharmacol. 2005;52:99-121. Abstract
53. Jonderko K, Jonderko G, Golab T. Effect of calcitonin on gastric emptying and on serum insulin and gastrin concentrations after ingestion of a mixed solid-liquid meal in humans. J Clin Gastroenterol. 1990 Feb;12(1):22-8. Abstract
54. Franke A, Nakchbandi IA, Schneider A, et al. The effect of ethanol and alcoholic beverages on gastric emptying of solid meals in humans. Alcohol Alcohol. 2005 May-Jun;40(3):187-93. Abstract
55. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005 Jun 1;71(11):2123-8. Abstract
56. Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019 May;42(5):731-754.Full text Abstract
57. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006 May;101(5):1129-39. Abstract
58. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000 Jun;95(6):1456-62. Abstract
59. Lin HC, Prather C, Fisher RS, et al. Measurement of gastrointestinal transit. Dig Dis Sci. 2005 Jun;50(6):989-1004. Abstract
60. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008 Mar;103(3):753-63.Full text Abstract
61. Bharucha AE, Camilleri M, Veil E, et al. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013 Jan;25(1):e60-9.Full text Abstract
62. Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008 Jan 15;27(2):186-96.Full text Abstract
63. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May;13(4):833-44. Abstract
64. Namin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil. 2007 Mar;19(3):196-202. Abstract
65. Fleisher DR, Gornowicz B, Adams K, et al. Cyclic vomiting syndrome in 41 adults: the illness, the patients, and problems of management. BMC Med. 2005 Dec 21;3:20.Full text Abstract
66. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Abstract
67. Koskenpato J, Kairemo K, Korppi-Tommola T, et al. Role of gastric emptying in functional dyspepsia: a scintigraphic study of 94 subjects. Dig Dis Sci. 1998 Jun;43(6):1154-8. Abstract
68. Soykan I, Chen J, Kendall BJ, et al. The rumination syndrome: clinical and manometric profile, therapy, and long-term outcome. Dig Dis Sci. 1997 Sep;42(9):1866-72. Abstract
69. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology. 1995 Apr;108(4):1024-9. Abstract
70. Storm AC, Fishman DS, et al. American Society for Gastrointestinal Endoscopy guideline on informed consent for GI endoscopic procedures. Gastrointest Endosc. 2022 Feb;95(2):207-15.e2.Full text Abstract
71. Keller J, Bassotti G, Clarke J, et al. Expert consensus document: advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol. 2018 Apr 6;15(5):291-308.Full text Abstract
72. Donohoe KJ, Maurer AH, Ziessman HA, et al; Society of Nuclear Medicine. Procedure guideline for adult solid-meal gastric-emptying study 3.0. Feb 2009 [internet publication].Full text
73. Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019 May;42(5):731-54.Full text Abstract
74. McCallum RW, Ricci DA, Rakatansky H, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983 Sep-Oct;6(5):463-7. Abstract
75. Ricci DA, Saltzman MB, Meyer C, et al. Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol. 1985 Feb;7(1):25-32. Abstract
76. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. Jul 2013 [internet publication].Full text
77. Ganzini L, Casey DE, Hoffman WF, et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993 Jun 28;153(12):1469-75. Abstract
78. Shaffer D, Butterfield M, Pamer C, et al. Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc (2003). 2004 Nov-Dec;44(6):661-5. Abstract
79. Cavero-Redondo I, Álvarez-Bueno C, Pozuelo-Carrascosa DP, et al. Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials. J Clin Nurs. 2015 Dec;24(23-24):3638-46. Abstract
80. Stewart JJ, Wood MJ, Wood CD, et al. Effects of motion sickness and antimotion sickness drugs on gastric function. J Clin Pharmacol. 1994 Jun;34(6):635-43. Abstract
81. Sawhney MS, Prakash C, Lustman PJ, et al. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci. 2007 Feb;52(2):418-24. Abstract
82. Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013 Dec 25;310(24):2640-9.Full text Abstract
83. Maurer AH, Krevsky B, Knight LC, et al. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy. J Nucl Med. 1996 May;37(5):818-22. Abstract
84. Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol. 2001 Jun 1;19(11):2898-904. Abstract
85. Tawfik MO, Bryuzgin V, Kourteva G; FEN-INT-20 Study Group. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opin. 2004 Mar;20(3):259-67. Abstract
86. Olausson EA, Störsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014 Mar;109(3):375-85. Abstract
87. Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006 Apr;18(4):263-83. Abstract
88. Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc. 2005 Jun;61(7):833-9. Abstract
89. Arts J, van Gool S, Caenepeel P, et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther. 2006 Aug 15;24(4):661-7. Abstract
90. Bai Y, Xu MJ, Yang X, et al. A systematic review on intrapyloric botulinum toxin injection for gastroparesis. Digestion. 2010;81(1):27-34. Abstract
91. Soffer E, Abell T, Lin Z, et al. Review article: gastric electrical stimulation for gastroparesis - physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther. 2009 Oct;30(7):681-94. Abstract
92. Chu H, Lin Z, Zhong L, et al. Treatment of high-frequency gastric electrical stimulation for gastroparesis. J Gastroenterol Hepatol. 2012 Jun;27(6):1017-26.Full text Abstract
93. Yin J, Abell TD, McCallum RW, et al. Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation. 2012 May-Jun;15(3):224-31. Abstract
94. McCallum RW, Sarosiek I, Parkman HP, et al. Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil. 2013 Oct;25(10):815-e636.Full text Abstract
95. Lin Z, McElhinney C, Sarosiek I, et al. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci. 2005 Jul;50(7):1328-34. Abstract
96. Cutts TF, Luo J, Starkebaum W, et al. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005 Feb;17(1):35-43. Abstract
97. O'Grady G, Egbuji JU, Du P, et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg. 2009 Aug;33(8):1693-701.Full text Abstract
98. National Institute for Health and Care Excellence (UK). Gastroelectrical stimulation for gastroparesis. May 2014 [internet publication].Full text
99. Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol. 2003 Oct;98(10):2122-9. Abstract
100. McCallum RW, Cynshi O; US Investigative Team. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther. 2007 Jul 1;26(1):107-16. Abstract
101. Mackie AD, Ferrington C, Cowan S, et al. The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis. Aliment Pharmacol Ther. 1991 Apr;5(2):135-42. Abstract
102. Asakawa H, Hayashi I, Fukui T, et al. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res Clin Pract. 2003 Sep;61(3):175-82. Abstract
103. He J, Wang Y, Ouyang X. Mosapride in treatment of diabetic gastroparesis: a meta-analysis. Chin J Gastroenterol. 2011;16(2):94-8.
104. Kuo B, Barnes CN, Nguyen DD, et al. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study. Aliment Pharmacol Ther. 2021 May;53(10):1090-7. Abstract
105. Seto K, Sasaki T, Katsunuma K, et al. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil. 2008 Sep;20(9):1051-9. Abstract
106. Dornonville de la Cour C, Lindström E, Norlén P, et al. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept. 2004 Aug 15;120(1-3):23-32. Abstract
107. Camilleri M, McCallum RW, Tack J, et al. Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study. Gastroenterology. 2017 Nov;153(5):1240-50;e2.Full text Abstract
108. Sallam HS, Chen JD. The prokinetic face of ghrelin. Int J Pept. 2010;2010:493614.Full text Abstract
109. Kim KH, Lee MS, Choi TY, et al. Acupuncture for symptomatic gastroparesis. Cochrane Database Syst Rev. 2018 Dec 18;12(12):CD009676.Full text Abstract
110. American Diabetes Association Professional Practice Committee; Draznin B, Aroda VR, Bakris G, et al. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes - 2022. Diabetes Care. 2022 Jan 1;45(suppl 1):S185-94.Full text Abstract
111. Tack J. Gastric motor disorders. Best Pract Res Clin Gastroenterol. 2007;21(4):633-44. Abstract
112. Lacy BE, Weiser K. Gastrointestinal motility disorders: an update. Dig Dis. 2006;24(3-4):228-42. Abstract
113. Thorn AR. Not just another case of nausea and vomiting: a review of postinfectious gastroparesis. J Am Acad Nurse Pract. 2010 Mar;22(3):125-33. Abstract
Use of this content is subject to our disclaimer